Literature DB >> 17997314

Inflammatory molecule expression in cerebral arteriovenous malformations.

Kingsley P Storer1, Jian Tu, Athula Karunanayaka, Michael K Morgan, Marcus A Stoodley.   

Abstract

Inflammatory proteins may play a role in the pathophysiology of cerebral arteriovenous malformations and their response to radiosurgery. The aim of this study was to compare the expression of inflammatory molecules in arteriovenous malformations (AVMs) with that in normal cerebral vessels. Fresh-frozen surgical specimens from 15 AVMs and three control specimens were studied. The expression of P- and E-selectin, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), platelet-endothelial cell adhesion molecule (PECAM-1) and von Willebrand factor were examined using immunohistochemistry. AVMs had significant upregulation of E-selectin. VCAM-1 and ICAM-1 upregulation was also observed in AVMs. Pre-operative embolization was associated with increased expression of E-selectin and VCAM-1. This study has provided further evidence that the endothelium of AVMs has different molecular properties than the endothelium of normal cerebral vasculature. Inflammatory molecules may be biologically relevant in the response of vascular malformations to radiosurgery and embolization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997314     DOI: 10.1016/j.jocn.2006.10.013

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation.

Authors:  Yi Guo; Tarik Tihan; Helen Kim; Christopher Hess; Michael T Lawton; William L Young; Yuanli Zhao; Hua Su
Journal:  Neuroimmunol Neuroinflamm       Date:  2014

Review 2.  Biology of cerebral arteriovenous malformations with a focus on inflammation.

Authors:  Nikolaos Mouchtouris; Pascal M Jabbour; Robert M Starke; David M Hasan; Mario Zanaty; Thana Theofanis; Dale Ding; Stavropoula I Tjoumakaris; Aaron S Dumont; George M Ghobrial; David Kung; Robert H Rosenwasser; Nohra Chalouhi
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-19       Impact factor: 6.200

3.  Endothelial signaling and the molecular basis of arteriovenous malformation.

Authors:  Deepak Atri; Bruno Larrivée; Anne Eichmann; Michael Simons
Journal:  Cell Mol Life Sci       Date:  2013-09-28       Impact factor: 9.261

4.  In vivo imaging of endothelial cell adhesion molecule expression after radiosurgery in an animal model of arteriovenous malformation.

Authors:  Newsha Raoufi-Rad; Lucinda S McRobb; Vivienne S Lee; David Bervini; Michael Grace; Jaysree Ukath; Joshua Mchattan; Varun K A Sreenivasan; T T Hong Duong; Zhenjun Zhao; Marcus A Stoodley
Journal:  PLoS One       Date:  2017-09-26       Impact factor: 3.240

5.  Evidence for endothelial-to-mesenchymal transition in human brain arteriovenous malformations.

Authors:  Lorelei D Shoemaker; Aaron K McCormick; Breanna M Allen; Steven D Chang
Journal:  Clin Transl Med       Date:  2020-06-21

Review 6.  Cellular loci involved in the development of brain arteriovenous malformations.

Authors:  Zahra Shabani; Joana Schuerger; Hua Su
Journal:  Front Hum Neurosci       Date:  2022-09-21       Impact factor: 3.473

7.  A combination of radiosurgery and soluble tissue factor enhances vascular targeting for experimental glioblastoma.

Authors:  Jian Tu; Zhiqiang Hu; Zhongbin Chen
Journal:  Biomed Res Int       Date:  2013-11-06       Impact factor: 3.411

8.  Endothelial gene expression and molecular changes in response to radiosurgery in in vitro and in vivo models of cerebral arteriovenous malformations.

Authors:  Jian Tu; Zhiqiang Hu; Zhongbin Chen
Journal:  Biomed Res Int       Date:  2013-10-02       Impact factor: 3.411

9.  Analysis of the Expression of Angioarchitecture-related Factors in Patients with Cerebral Arteriovenous Malformation.

Authors:  Guang-Zhong Chen; Yu Ke; Kun Qin; Meng-Qi Dong; Shao-Jian Zeng; Xiao-Feng Lin; Sheng-Quan Zhan; Kai Tang; Chao Peng; Xiao-Wen Ding; Dong Zhou
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.